Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Johnson

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Pain|September 29, 2001
Acute pain in herpes zoster: the famciclovir database projectRobert H Dworkin, Elna M Nagasako, Robert W Johnson, et al.
Journal of the American Academy of Dermatology|June 14, 2002
Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgiaElna M Nagasako, Robert W Johnson, David R J Griffin, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Recent Developments in Mass Spectrometry to Support Next-Generation Synthesis and ScreeningNari N Talaty, Robert W Johnson, James Sawicki, et al.
BMC Medicine|June 23, 2010
The impact of herpes zoster and post-herpetic neuralgia on quality-of-lifeRobert W Johnson, Didier Bouhassira, George Kassianos, et al.
Plant Physiology|April 5, 2005
Antifreeze proteins modify the freezing process in plantaMarilyn Griffith, Chelsey Lumb, Steven B Wiseman, et al.
Plos Medicine|July 15, 2005
Analgesic therapy in postherpetic neuralgia: a quantitative systematic reviewKathleen Hempenstall, Turo J Nurmikko, Robert W Johnson, et al.
Journal of Medical Virology|March 11, 2003
Geographic and racial aspects of herpes zosterElna M Nagasako, Robert W Johnson, David R J Griffin, et al.
Vaccine|December 15, 2005
The burden of Herpes Zoster: a prospective population based studyFiona T Scott, Robert W Johnson, Mary Leedham-Green, et al.
European Journal of Pain (London, England)|January 24, 2006
Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?Pietro G Coen, Fiona Scott, Mary Leedham-Green, et al.
Vaccine|February 22, 2018
Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trialsMartina Kovac, Himal Lal, Anthony L Cunningham, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Pain|September 29, 2001
Acute pain in herpes zoster: the famciclovir database projectRobert H Dworkin, Elna M Nagasako, Robert W Johnson, et al.
Journal of the American Academy of Dermatology|June 14, 2002
Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgiaElna M Nagasako, Robert W Johnson, David R J Griffin, et al.
ACS Medicinal Chemistry Letters|June 14, 2023
Recent Developments in Mass Spectrometry to Support Next-Generation Synthesis and ScreeningNari N Talaty, Robert W Johnson, James Sawicki, et al.
BMC Medicine|June 23, 2010
The impact of herpes zoster and post-herpetic neuralgia on quality-of-lifeRobert W Johnson, Didier Bouhassira, George Kassianos, et al.
Plant Physiology|April 5, 2005
Antifreeze proteins modify the freezing process in plantaMarilyn Griffith, Chelsey Lumb, Steven B Wiseman, et al.
Plos Medicine|July 15, 2005
Analgesic therapy in postherpetic neuralgia: a quantitative systematic reviewKathleen Hempenstall, Turo J Nurmikko, Robert W Johnson, et al.
Journal of Medical Virology|March 11, 2003
Geographic and racial aspects of herpes zosterElna M Nagasako, Robert W Johnson, David R J Griffin, et al.
Vaccine|December 15, 2005
The burden of Herpes Zoster: a prospective population based studyFiona T Scott, Robert W Johnson, Mary Leedham-Green, et al.
European Journal of Pain (London, England)|January 24, 2006
Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?Pietro G Coen, Fiona Scott, Mary Leedham-Green, et al.
Vaccine|February 22, 2018
Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trialsMartina Kovac, Himal Lal, Anthony L Cunningham, et al.
Pageof 6